In two years, the Tamil Nadu Medical Services Corporation (TNMSC) has blacklisted 40 products - drugs and injections - and three firms primarily for failing to meet quality control norms.
According to data from TNMSC, an organisation that was set up to streamline the procurement, storage and distribution of essential drugs for government hospitals, 22 products were blacklisted for quality failures during 2023-2024. During 2024-2025, 26 products were blacklisted, of which 22 were quality-related and four for non-execution of purchase orders. A total of 14 products were blacklisted so far in 2025, all related to quality failures.
Firm-wise, TNMSC blacklisted five firms during 2023-2024 (two for non-execution of purchase orders and three on quality grounds. While two firms were blacklisted during 2024-2025, one was blacklisted so far this year on quality grounds.
Also Read: Not business as usual: On upholding India’s reputation for quality drugs
Year Number of blacklisted firms Reasons Number of products blacklisted Reasons
